138 related articles for article (PubMed ID: 29854499)
1. Protracted Clonal Trajectory of a
Langabeer SE; Haslam K; Smyth MA; Quinn J; Murphy PT
Case Rep Hematol; 2018; 2018():8713020. PubMed ID: 29854499
[TBL] [Abstract][Full Text] [Related]
2. JAK2 V617F-positive acute myeloid leukaemia (AML): a comparison between de novo AML and secondary AML transformed from an underlying myeloproliferative neoplasm. A study from the Bone Marrow Pathology Group.
Aynardi J; Manur R; Hess PR; Chekol S; Morrissette JJD; Babushok D; Hexner E; Rogers HJ; Hsi ED; Margolskee E; Orazi A; Hasserjian R; Bagg A
Br J Haematol; 2018 Jul; 182(1):78-85. PubMed ID: 29767839
[TBL] [Abstract][Full Text] [Related]
3. Janus kinase 2 variants associated with the transformation of myeloproliferative neoplasms into acute myeloid leukemia.
Benton CB; Boddu PC; DiNardo CD; Bose P; Wang F; Assi R; Pemmaraju N; Kc D; Pierce S; Patel K; Konopleva M; Ravandi F; Garcia-Manero G; Kadia TM; Cortes J; Kantarjian HM; Andreeff M; Verstovsek S
Cancer; 2019 Jun; 125(11):1855-1866. PubMed ID: 30811597
[TBL] [Abstract][Full Text] [Related]
4. An Polycythemia Vera Evolve from Acute Myeloid Leukemia? Report of a Case Showing a Simultaneous Minor
Borsellino B; Savi A; Pascale MR; Meddi E; Del Principe MI; Cristiano A; Ottone T; Rapanotti MC; Divona M; Travaglini S; Attardi E; Palmieri R; Buzzatti E; Buccisano F; Voso MT
Mediterr J Hematol Infect Dis; 2022; 14(1):e2022058. PubMed ID: 35865394
[TBL] [Abstract][Full Text] [Related]
5. Secondary Acute Myeloid Leukemia in a One-Year-Old Girl Diagnosed with JAK2-V617F Mutation Positive Myeloproliferative Neoplasm.
Woods GM; Bajwa RP; Kahwash SB; Guinipero T
Case Rep Med; 2014; 2014():473297. PubMed ID: 24744787
[TBL] [Abstract][Full Text] [Related]
6. JAK2 V617F mutation in myelodysplastic syndrome, myelodysplastic syndrome/myeloproliferative neoplasm, unclassifiable, refractory anemia with ring sideroblasts with thrombocytosis, and acute myeloid leukemia.
Jekarl DW; Han SB; Kim M; Lim J; Oh EJ; Kim Y; Kim HJ; Min WS; Han K
Korean J Hematol; 2010 Mar; 45(1):46-50. PubMed ID: 21120162
[TBL] [Abstract][Full Text] [Related]
7. Myeloproliferative Neoplasm or Reactive Process? A Rare Case of Acute Myeloid Leukemia and Transient Posttreatment Megakaryocytic Hyperplasia with JAK-2 Mutation.
Wang S; Yan J; Zhou G; Heintzelman R; Hou JS
Case Rep Hematol; 2016; 2016():6054017. PubMed ID: 27752371
[TBL] [Abstract][Full Text] [Related]
8. Acute promyelocytic leukemia co-existing with JAK2 V617F positive myeloproliferative neoplasm: a case report.
Mamorska-Dyga A; Wu J; Khattar P; Ronny FM; Islam H; Seiter K; Liu D
Stem Cell Investig; 2016; 3():8. PubMed ID: 27358900
[TBL] [Abstract][Full Text] [Related]
9. Outcome of patients with splanchnic venous thrombosis presenting without overt MPN: a role for the JAK2 V617F mutation re-evaluation.
Colaizzo D; Amitrano L; Guardascione MA; Tiscia GL; D'Andrea G; Longo VA; Grandone E; Margaglione M
Thromb Res; 2013 Aug; 132(2):e99-e104. PubMed ID: 23916380
[TBL] [Abstract][Full Text] [Related]
10. JAK2V617F mutations in myeloid malignancies: single center experience.
Panovska-Stavridis I; Cevreska L; Ivanovski M; Stojanovik A; Lozance M; Matevska N; Dimovski A; Serafimoski V
Prilozi; 2008 Dec; 29(2):257-67. PubMed ID: 19259051
[TBL] [Abstract][Full Text] [Related]
11. FLT3 mutations in myeloproliferative neoplasms: the Beaumont experience.
Williams L; Kelley HH; Meng X; Prada A; Crisan D
Diagn Mol Pathol; 2013 Sep; 22(3):156-60. PubMed ID: 23846442
[TBL] [Abstract][Full Text] [Related]
12. Changing concepts of diagnostic criteria of myeloproliferative disorders and the molecular etiology and classification of myeloproliferative neoplasms: from Dameshek 1950 to Vainchenker 2005 and beyond.
Michiels JJ; Berneman Z; Schroyens W; De Raeve H
Acta Haematol; 2015; 133(1):36-51. PubMed ID: 25116092
[TBL] [Abstract][Full Text] [Related]
13. Clonal dynamics in a case of acute monoblastic leukemia that later developed myeloproliferative neoplasm.
Sato S; Itonaga H; Taguchi M; Sawayama Y; Imanishi D; Tsushima H; Hata T; Moriuchi Y; Mishima H; Kinoshita A; Yoshiura KI; Miyazaki Y
Int J Hematol; 2018 Aug; 108(2):213-217. PubMed ID: 29417354
[TBL] [Abstract][Full Text] [Related]
14. Association between thromboembolic events and the JAK2 V617F mutation in myeloproliferative neoplasms.
Takata Y; Seki R; Kanajii T; Nohara M; Koteda S; Kawaguchi K; Nomura K; Nakamura T; Morishige S; Oku E; Osaki K; Hashiguchi E; Mouri F; Yoshimoto K; Nagafuji K; Okamura T
Kurume Med J; 2014; 60(3-4):89-97. PubMed ID: 24858412
[TBL] [Abstract][Full Text] [Related]
15. A patient with a 20-year lag phase between JAK2-V617F+ myeloproliferation and NPM1-mutated AML arguing against a common origin of disease.
Roug AS; Nyvold CG; Juhl-Christensen C; Christensen M; Schnittger S; Hokland P
Eur J Haematol; 2011 Nov; 87(5):461-3. PubMed ID: 21689158
[TBL] [Abstract][Full Text] [Related]
16. Genomic aberrations of myeloproliferative and myelodysplastic/myeloproliferative neoplasms in chronic phase and during disease progression.
Hahm C; Huh HJ; Mun YC; Seong CM; Chung WS; Huh J
Int J Lab Hematol; 2015 Apr; 37(2):181-9. PubMed ID: 24845343
[TBL] [Abstract][Full Text] [Related]
17. [Analysis of Essential Thrombocythemia to Acute Myeloid Leukemia].
Lin P; Xie RT; Zhang YL; Zhang XY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Apr; 28(2):411-417. PubMed ID: 32319371
[TBL] [Abstract][Full Text] [Related]
18. A rare atypical chronic myeloid leukemia BCR-ABL1 negative with concomitant
Gao T; Yu C; Xia S; Liang T; Gu X; Liu Z
Ther Adv Hematol; 2020; 11():2040620720927105. PubMed ID: 32782768
[TBL] [Abstract][Full Text] [Related]
19. Clinical Implications of Quantitative JAK2 V617F Analysis using Droplet Digital PCR in Myeloproliferative Neoplasms.
Lee E; Lee KJ; Park H; Chung JY; Lee MN; Chang MH; Yoo J; Lee H; Kong SY; Eom HS
Ann Lab Med; 2018 Mar; 38(2):147-154. PubMed ID: 29214759
[TBL] [Abstract][Full Text] [Related]
20. The JAK2 V617F mutational status and allele burden may be related with the risk of venous thromboembolic events in patients with Philadelphia-negative myeloproliferative neoplasms.
Borowczyk M; Wojtaszewska M; Lewandowski K; Gil L; Lewandowska M; Lehmann-Kopydłowska A; Kroll-Balcerzak R; Balcerzak A; Iwoła M; Michalak M; Komarnicki M
Thromb Res; 2015 Feb; 135(2):272-80. PubMed ID: 25559461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
